Kodiak Sciences to Present at American Chemical Society Fall 2025

PALO ALTO, Calif., Aug. 19, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, announced today that senior management will present the Company's pipeline programs in glaucoma at the American Chemical Society (ACS) Fall 2025 Meeting on Tuesday, August 19, 2025, in Washington, D.C.

Read more at prnewswire.com